Rosacea treatment guideline for The Netherlands Article Swipe
Esther J van Zuuren
,
Mireille M. D. van der Linden
,
B.W.M. Arents
·
YOU?
·
· 2020
· Open Access
·
· DOI: https://doi.org/10.1111/bjd.19073
YOU?
·
· 2020
· Open Access
·
· DOI: https://doi.org/10.1111/bjd.19073
The authors of this research letter developed a treatment guideline for patients with rosacea in The Netherlands, based on a recently published review of all evidence on treating rosacea. The Dutch Society of Dermatology and Venereology funded the project and provided two staff members who supported the working group (WG). The WG consisted further of four dermatologists, a general practitioner, an ophthalmologist, a plastic surgeon, two skin therapists and a patient. For the process the most rigorous methodological standards were used. Ten health questions were covered in the guideline which assessed a range of self-care measures and treatment options, considering effectiveness and safety. Recommendations for these health questions were made by combining the evidence with values and preferences of patients, costs and availability. Recommendations are either strong (‘recommend’) or weak (‘consider’), and for or against a treatment. The authors presented the relevant treatments in an algorithm (Fig 1). Not mentioned are topical oxymetazoline for persistent redness (not available in The Netherlands) and those treatments with recommendations against. Considering rosacea has a negative impact on quality of life, a full chapter was dedicated to this in the guideline. In this chapter the authors recommended that doctors address quality of life, treatment satisfaction, social and professional functioning, and psychological well-being, in order to optimise treatment. In addition, a comprehensive patient information leaflet was made available on rosacea, its treatment and self-care. Figure 1Open in figure viewerPowerPoint Rosacea treatment algorithm. Consider = weak recommendation, Recommended = strong recommendation, b.i.d. = twice daily, q.d. = once daily. Erythema = redness. Papules = pimples. Pustules = pus-filled spots. Phyma = thickened nose. Telangiectasia= visible small blood vessels. This is a summary of the study: Rosacea treatment guideline for the Netherlands
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1111/bjd.19073
- https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjd.19073
- OA Status
- bronze
- Cited By
- 2
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4214634594
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4214634594Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1111/bjd.19073Digital Object Identifier
- Title
-
Rosacea treatment guideline for The NetherlandsWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2020Year of publication
- Publication date
-
2020-06-01Full publication date if available
- Authors
-
Esther J van Zuuren, Mireille M. D. van der Linden, B.W.M. ArentsList of authors in order
- Landing page
-
https://doi.org/10.1111/bjd.19073Publisher landing page
- PDF URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjd.19073Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjd.19073Direct OA link when available
- Concepts
-
Rosacea, Guideline, Venereology, Medicine, Quality of life (healthcare), Dermatology, Health care, MEDLINE, Family medicine, Nursing, Pathology, Political science, Economic growth, Acne, Law, EconomicsTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
2Total citation count in OpenAlex
- Citations by year (recent)
-
2022: 1, 2021: 1Per-year citation counts (last 5 years)
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4214634594 |
|---|---|
| doi | https://doi.org/10.1111/bjd.19073 |
| ids.doi | https://doi.org/10.1111/bjd.19073 |
| ids.openalex | https://openalex.org/W4214634594 |
| fwci | 0.41675201 |
| type | article |
| title | Rosacea treatment guideline for The Netherlands |
| biblio.issue | 6 |
| biblio.volume | 182 |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11553 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9995999932289124 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2708 |
| topics[0].subfield.display_name | Dermatology |
| topics[0].display_name | Acne and Rosacea Treatments and Effects |
| topics[1].id | https://openalex.org/T11172 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9599000215530396 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2708 |
| topics[1].subfield.display_name | Dermatology |
| topics[1].display_name | Dermatologic Treatments and Research |
| topics[2].id | https://openalex.org/T11013 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9129999876022339 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2708 |
| topics[2].subfield.display_name | Dermatology |
| topics[2].display_name | Skin Protection and Aging |
| is_xpac | False |
| apc_list.value | 3416 |
| apc_list.currency | GBP |
| apc_list.value_usd | 4190 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2778081122 |
| concepts[0].level | 3 |
| concepts[0].score | 0.9714717864990234 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q831530 |
| concepts[0].display_name | Rosacea |
| concepts[1].id | https://openalex.org/C2780182762 |
| concepts[1].level | 2 |
| concepts[1].score | 0.8243404626846313 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1630279 |
| concepts[1].display_name | Guideline |
| concepts[2].id | https://openalex.org/C2779437838 |
| concepts[2].level | 2 |
| concepts[2].score | 0.8226659893989563 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1784782 |
| concepts[2].display_name | Venereology |
| concepts[3].id | https://openalex.org/C71924100 |
| concepts[3].level | 0 |
| concepts[3].score | 0.7294559478759766 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[3].display_name | Medicine |
| concepts[4].id | https://openalex.org/C2779951463 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5527997612953186 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q7268788 |
| concepts[4].display_name | Quality of life (healthcare) |
| concepts[5].id | https://openalex.org/C16005928 |
| concepts[5].level | 1 |
| concepts[5].score | 0.46941930055618286 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q171171 |
| concepts[5].display_name | Dermatology |
| concepts[6].id | https://openalex.org/C160735492 |
| concepts[6].level | 2 |
| concepts[6].score | 0.4374881088733673 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q31207 |
| concepts[6].display_name | Health care |
| concepts[7].id | https://openalex.org/C2779473830 |
| concepts[7].level | 2 |
| concepts[7].score | 0.4332996606826782 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q1540899 |
| concepts[7].display_name | MEDLINE |
| concepts[8].id | https://openalex.org/C512399662 |
| concepts[8].level | 1 |
| concepts[8].score | 0.3869715929031372 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q3505712 |
| concepts[8].display_name | Family medicine |
| concepts[9].id | https://openalex.org/C159110408 |
| concepts[9].level | 1 |
| concepts[9].score | 0.20296445488929749 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q121176 |
| concepts[9].display_name | Nursing |
| concepts[10].id | https://openalex.org/C142724271 |
| concepts[10].level | 1 |
| concepts[10].score | 0.10966476798057556 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[10].display_name | Pathology |
| concepts[11].id | https://openalex.org/C17744445 |
| concepts[11].level | 0 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q36442 |
| concepts[11].display_name | Political science |
| concepts[12].id | https://openalex.org/C50522688 |
| concepts[12].level | 1 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q189833 |
| concepts[12].display_name | Economic growth |
| concepts[13].id | https://openalex.org/C2777673923 |
| concepts[13].level | 2 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q79928 |
| concepts[13].display_name | Acne |
| concepts[14].id | https://openalex.org/C199539241 |
| concepts[14].level | 1 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q7748 |
| concepts[14].display_name | Law |
| concepts[15].id | https://openalex.org/C162324750 |
| concepts[15].level | 0 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q8134 |
| concepts[15].display_name | Economics |
| keywords[0].id | https://openalex.org/keywords/rosacea |
| keywords[0].score | 0.9714717864990234 |
| keywords[0].display_name | Rosacea |
| keywords[1].id | https://openalex.org/keywords/guideline |
| keywords[1].score | 0.8243404626846313 |
| keywords[1].display_name | Guideline |
| keywords[2].id | https://openalex.org/keywords/venereology |
| keywords[2].score | 0.8226659893989563 |
| keywords[2].display_name | Venereology |
| keywords[3].id | https://openalex.org/keywords/medicine |
| keywords[3].score | 0.7294559478759766 |
| keywords[3].display_name | Medicine |
| keywords[4].id | https://openalex.org/keywords/quality-of-life |
| keywords[4].score | 0.5527997612953186 |
| keywords[4].display_name | Quality of life (healthcare) |
| keywords[5].id | https://openalex.org/keywords/dermatology |
| keywords[5].score | 0.46941930055618286 |
| keywords[5].display_name | Dermatology |
| keywords[6].id | https://openalex.org/keywords/health-care |
| keywords[6].score | 0.4374881088733673 |
| keywords[6].display_name | Health care |
| keywords[7].id | https://openalex.org/keywords/medline |
| keywords[7].score | 0.4332996606826782 |
| keywords[7].display_name | MEDLINE |
| keywords[8].id | https://openalex.org/keywords/family-medicine |
| keywords[8].score | 0.3869715929031372 |
| keywords[8].display_name | Family medicine |
| keywords[9].id | https://openalex.org/keywords/nursing |
| keywords[9].score | 0.20296445488929749 |
| keywords[9].display_name | Nursing |
| keywords[10].id | https://openalex.org/keywords/pathology |
| keywords[10].score | 0.10966476798057556 |
| keywords[10].display_name | Pathology |
| language | en |
| locations[0].id | doi:10.1111/bjd.19073 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S45720283 |
| locations[0].source.issn | 0007-0963, 1365-2133 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0007-0963 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | British Journal of Dermatology |
| locations[0].source.host_organization | https://openalex.org/P4310311648 |
| locations[0].source.host_organization_name | Oxford University Press |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310311648 |
| locations[0].license | |
| locations[0].pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjd.19073 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | British Journal of Dermatology |
| locations[0].landing_page_url | https://doi.org/10.1111/bjd.19073 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5028843574 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-4780-0182 |
| authorships[0].author.display_name | Esther J van Zuuren |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | E.J. Zuuren |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5106266415 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Mireille M. D. van der Linden |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | M.M.D. Linden |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5017819615 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-6884-8014 |
| authorships[2].author.display_name | B.W.M. Arents |
| authorships[2].author_position | last |
| authorships[2].raw_author_name | B.W.M. Arents |
| authorships[2].is_corresponding | False |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjd.19073 |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Rosacea treatment guideline for The Netherlands |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11553 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9995999932289124 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2708 |
| primary_topic.subfield.display_name | Dermatology |
| primary_topic.display_name | Acne and Rosacea Treatments and Effects |
| related_works | https://openalex.org/W4390051207, https://openalex.org/W2350918985, https://openalex.org/W2410394339, https://openalex.org/W2138345037, https://openalex.org/W2004990246, https://openalex.org/W2171021733, https://openalex.org/W2124975129, https://openalex.org/W1988102891, https://openalex.org/W2135644518, https://openalex.org/W2384839602 |
| cited_by_count | 2 |
| counts_by_year[0].year | 2022 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2021 |
| counts_by_year[1].cited_by_count | 1 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1111/bjd.19073 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S45720283 |
| best_oa_location.source.issn | 0007-0963, 1365-2133 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0007-0963 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | British Journal of Dermatology |
| best_oa_location.source.host_organization | https://openalex.org/P4310311648 |
| best_oa_location.source.host_organization_name | Oxford University Press |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310311648 |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjd.19073 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | British Journal of Dermatology |
| best_oa_location.landing_page_url | https://doi.org/10.1111/bjd.19073 |
| primary_location.id | doi:10.1111/bjd.19073 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S45720283 |
| primary_location.source.issn | 0007-0963, 1365-2133 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0007-0963 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | British Journal of Dermatology |
| primary_location.source.host_organization | https://openalex.org/P4310311648 |
| primary_location.source.host_organization_name | Oxford University Press |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310311648 |
| primary_location.license | |
| primary_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjd.19073 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | British Journal of Dermatology |
| primary_location.landing_page_url | https://doi.org/10.1111/bjd.19073 |
| publication_date | 2020-06-01 |
| publication_year | 2020 |
| referenced_works_count | 0 |
| abstract_inverted_index.= | 238, 242, 246, 250, 254, 257, 260, 264 |
| abstract_inverted_index.a | 7, 19, 57, 62, 69, 91, 135, 170, 177, 215, 274 |
| abstract_inverted_index.In | 187, 213 |
| abstract_inverted_index.WG | 51 |
| abstract_inverted_index.an | 60, 144 |
| abstract_inverted_index.by | 110 |
| abstract_inverted_index.in | 14, 86, 143, 158, 184, 208, 231 |
| abstract_inverted_index.is | 273 |
| abstract_inverted_index.of | 2, 23, 32, 54, 93, 118, 175, 197, 276 |
| abstract_inverted_index.on | 18, 26, 173, 223 |
| abstract_inverted_index.or | 128, 133 |
| abstract_inverted_index.to | 182, 210 |
| abstract_inverted_index.1). | 147 |
| abstract_inverted_index.For | 71 |
| abstract_inverted_index.Not | 148 |
| abstract_inverted_index.Ten | 81 |
| abstract_inverted_index.The | 0, 15, 29, 50, 137, 159 |
| abstract_inverted_index.all | 24 |
| abstract_inverted_index.and | 34, 39, 68, 96, 101, 116, 121, 131, 161, 202, 205, 227 |
| abstract_inverted_index.are | 124, 150 |
| abstract_inverted_index.for | 10, 104, 132, 153, 282 |
| abstract_inverted_index.has | 169 |
| abstract_inverted_index.its | 225 |
| abstract_inverted_index.the | 37, 46, 72, 74, 87, 112, 140, 185, 190, 277, 283 |
| abstract_inverted_index.two | 41, 65 |
| abstract_inverted_index.was | 180, 220 |
| abstract_inverted_index.who | 44 |
| abstract_inverted_index.(Fig | 146 |
| abstract_inverted_index.(not | 156 |
| abstract_inverted_index.This | 272 |
| abstract_inverted_index.four | 55 |
| abstract_inverted_index.full | 178 |
| abstract_inverted_index.made | 109, 221 |
| abstract_inverted_index.most | 75 |
| abstract_inverted_index.once | 251 |
| abstract_inverted_index.q.d. | 249 |
| abstract_inverted_index.skin | 66 |
| abstract_inverted_index.that | 193 |
| abstract_inverted_index.this | 3, 183, 188 |
| abstract_inverted_index.weak | 129, 239 |
| abstract_inverted_index.were | 79, 84, 108 |
| abstract_inverted_index.with | 12, 114, 164 |
| abstract_inverted_index.(WG). | 49 |
| abstract_inverted_index.1Open | 230 |
| abstract_inverted_index.Dutch | 30 |
| abstract_inverted_index.Phyma | 263 |
| abstract_inverted_index.based | 17 |
| abstract_inverted_index.blood | 270 |
| abstract_inverted_index.costs | 120 |
| abstract_inverted_index.group | 48 |
| abstract_inverted_index.life, | 176, 198 |
| abstract_inverted_index.nose. | 266 |
| abstract_inverted_index.order | 209 |
| abstract_inverted_index.range | 92 |
| abstract_inverted_index.small | 269 |
| abstract_inverted_index.staff | 42 |
| abstract_inverted_index.these | 105 |
| abstract_inverted_index.those | 162 |
| abstract_inverted_index.twice | 247 |
| abstract_inverted_index.used. | 80 |
| abstract_inverted_index.which | 89 |
| abstract_inverted_index.Figure | 229 |
| abstract_inverted_index.b.i.d. | 245 |
| abstract_inverted_index.daily, | 248 |
| abstract_inverted_index.daily. | 252 |
| abstract_inverted_index.either | 125 |
| abstract_inverted_index.figure | 232 |
| abstract_inverted_index.funded | 36 |
| abstract_inverted_index.health | 82, 106 |
| abstract_inverted_index.impact | 172 |
| abstract_inverted_index.letter | 5 |
| abstract_inverted_index.review | 22 |
| abstract_inverted_index.social | 201 |
| abstract_inverted_index.spots. | 262 |
| abstract_inverted_index.strong | 126, 243 |
| abstract_inverted_index.study: | 278 |
| abstract_inverted_index.values | 115 |
| abstract_inverted_index.Papules | 256 |
| abstract_inverted_index.Rosacea | 234, 279 |
| abstract_inverted_index.Society | 31 |
| abstract_inverted_index.address | 195 |
| abstract_inverted_index.against | 134 |
| abstract_inverted_index.authors | 1, 138, 191 |
| abstract_inverted_index.chapter | 179, 189 |
| abstract_inverted_index.covered | 85 |
| abstract_inverted_index.doctors | 194 |
| abstract_inverted_index.further | 53 |
| abstract_inverted_index.general | 58 |
| abstract_inverted_index.leaflet | 219 |
| abstract_inverted_index.members | 43 |
| abstract_inverted_index.patient | 217 |
| abstract_inverted_index.plastic | 63 |
| abstract_inverted_index.process | 73 |
| abstract_inverted_index.project | 38 |
| abstract_inverted_index.quality | 174, 196 |
| abstract_inverted_index.redness | 155 |
| abstract_inverted_index.rosacea | 13, 168 |
| abstract_inverted_index.safety. | 102 |
| abstract_inverted_index.summary | 275 |
| abstract_inverted_index.topical | 151 |
| abstract_inverted_index.visible | 268 |
| abstract_inverted_index.working | 47 |
| abstract_inverted_index.Consider | 237 |
| abstract_inverted_index.Erythema | 253 |
| abstract_inverted_index.Pustules | 259 |
| abstract_inverted_index.against. | 166 |
| abstract_inverted_index.assessed | 90 |
| abstract_inverted_index.evidence | 25, 113 |
| abstract_inverted_index.measures | 95 |
| abstract_inverted_index.negative | 171 |
| abstract_inverted_index.optimise | 211 |
| abstract_inverted_index.options, | 98 |
| abstract_inverted_index.patient. | 70 |
| abstract_inverted_index.patients | 11 |
| abstract_inverted_index.pimples. | 258 |
| abstract_inverted_index.provided | 40 |
| abstract_inverted_index.recently | 20 |
| abstract_inverted_index.redness. | 255 |
| abstract_inverted_index.relevant | 141 |
| abstract_inverted_index.research | 4 |
| abstract_inverted_index.rigorous | 76 |
| abstract_inverted_index.rosacea, | 224 |
| abstract_inverted_index.rosacea. | 28 |
| abstract_inverted_index.surgeon, | 64 |
| abstract_inverted_index.treating | 27 |
| abstract_inverted_index.vessels. | 271 |
| abstract_inverted_index.addition, | 214 |
| abstract_inverted_index.algorithm | 145 |
| abstract_inverted_index.available | 157, 222 |
| abstract_inverted_index.combining | 111 |
| abstract_inverted_index.consisted | 52 |
| abstract_inverted_index.dedicated | 181 |
| abstract_inverted_index.developed | 6 |
| abstract_inverted_index.guideline | 9, 88, 281 |
| abstract_inverted_index.mentioned | 149 |
| abstract_inverted_index.patients, | 119 |
| abstract_inverted_index.presented | 139 |
| abstract_inverted_index.published | 21 |
| abstract_inverted_index.questions | 83, 107 |
| abstract_inverted_index.self-care | 94 |
| abstract_inverted_index.standards | 78 |
| abstract_inverted_index.supported | 45 |
| abstract_inverted_index.thickened | 265 |
| abstract_inverted_index.treatment | 8, 97, 199, 226, 235, 280 |
| abstract_inverted_index.algorithm. | 236 |
| abstract_inverted_index.guideline. | 186 |
| abstract_inverted_index.persistent | 154 |
| abstract_inverted_index.pus-filled | 261 |
| abstract_inverted_index.self-care. | 228 |
| abstract_inverted_index.therapists | 67 |
| abstract_inverted_index.treatment. | 136, 212 |
| abstract_inverted_index.treatments | 142, 163 |
| abstract_inverted_index.Considering | 167 |
| abstract_inverted_index.Dermatology | 33 |
| abstract_inverted_index.Netherlands | 284 |
| abstract_inverted_index.Recommended | 241 |
| abstract_inverted_index.Venereology | 35 |
| abstract_inverted_index.considering | 99 |
| abstract_inverted_index.information | 218 |
| abstract_inverted_index.preferences | 117 |
| abstract_inverted_index.recommended | 192 |
| abstract_inverted_index.well-being, | 207 |
| abstract_inverted_index.Netherlands) | 160 |
| abstract_inverted_index.Netherlands, | 16 |
| abstract_inverted_index.functioning, | 204 |
| abstract_inverted_index.professional | 203 |
| abstract_inverted_index.availability. | 122 |
| abstract_inverted_index.comprehensive | 216 |
| abstract_inverted_index.effectiveness | 100 |
| abstract_inverted_index.oxymetazoline | 152 |
| abstract_inverted_index.practitioner, | 59 |
| abstract_inverted_index.psychological | 206 |
| abstract_inverted_index.satisfaction, | 200 |
| abstract_inverted_index.methodological | 77 |
| abstract_inverted_index.Recommendations | 103, 123 |
| abstract_inverted_index.Telangiectasia= | 267 |
| abstract_inverted_index.dermatologists, | 56 |
| abstract_inverted_index.recommendation, | 240, 244 |
| abstract_inverted_index.recommendations | 165 |
| abstract_inverted_index.ophthalmologist, | 61 |
| abstract_inverted_index.viewerPowerPoint | 233 |
| abstract_inverted_index.(‘consider’), | 130 |
| abstract_inverted_index.(‘recommend’) | 127 |
| cited_by_percentile_year.max | 94 |
| cited_by_percentile_year.min | 89 |
| countries_distinct_count | 0 |
| institutions_distinct_count | 3 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/17 |
| sustainable_development_goals[0].score | 0.4300000071525574 |
| sustainable_development_goals[0].display_name | Partnerships for the goals |
| citation_normalized_percentile.value | 0.64942191 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |